Zhao Wancheng, Xiao Yunyun, Zhao Wei, Yang Qing, Bi Fangfang
Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, China.
Department of Gynecology and Obstetrics, Dalian Obstetrics and Gynecology Hospital Affiliated to Dalian Medical University & Dalian Maternal and Child Health Care Hospital, Dalian, China.
Front Oncol. 2021 Jun 17;11:682849. doi: 10.3389/fonc.2021.682849. eCollection 2021.
To compare the survival and recurrence outcomes between open and laparoscopic radically hysterectomy (RH) for stage IA2-IIA2 cervical cancer based on Federation International of Gynecology and Obstetrics (FIGO) 2018.
Data of 1,373 early cervical cancer patients undergoing open or laparoscopic radically hysterectomy at ShengJing Hospital of China Medical University between January 1, 2013, and December 31, 2016, were retrospectively reviewed. Propensity score-based inverse probability of treatment weighting (PS-IPTW) was used to balance the covariates between the two groups.
A total of 705 cervical cancer patients of FIGO 2009 stage IA2-IIA2 were finally enrolled in this study. After IPTW adjustment, the OS (HR = 2.095, 95% CI: 1.233-3.562, P = 0.006) and PFS (HR = 1.950, 95%CI: 1.194-3.184, P = 0.008) rates were significantly higher in the open RH (ORH) group compared with the laparoscopic RH (LRH) group. Then after re-staging according to the FIGO 2018 staging system, 561 patients still belonged to stage IA2-IIA2, 144 patients were upgraded to stage IIIC1p-IIIC2p. The ORH group had a significantly superior OS (HR = 1.977, 95%CI: 1.077-3.626, P = 0.028) and PFS (HR = 1.811, 95%CI: 1.046-3.134, P = 0.034) compared with the LRH group after PS-IPTW analysis. Furthermore, in patients with no high and intermediate risks, difference of the OS (HR = 1.386, 95%CI: 0.287-6.69, P = 0.684) and PFS (HR = 1.524, 95%CI: 0.363-6.396, P = 0.565) rates between the two groups were with no statistical meaning.
Outcomes of this retrospective cohort study were in compliance with indications for ORH recommended by the National Comprehensive Cancer Network guidelines Version 1, 2021. However, LRH showed non-inferiority for patients with no prognostic risk factors compared with ORH.
基于国际妇产科联盟(FIGO)2018年标准,比较开放性与腹腔镜下根治性子宫切除术(RH)治疗IA2-IIA2期宫颈癌的生存和复发结局。
回顾性分析2013年1月1日至2016年12月31日在中国医科大学附属盛京医院接受开放性或腹腔镜下根治性子宫切除术的1373例早期宫颈癌患者的数据。采用基于倾向评分的治疗权重逆概率法(PS-IPTW)平衡两组之间的协变量。
本研究最终纳入705例FIGO 2009分期为IA2-IIA2期的宫颈癌患者。经IPTW调整后,开放性根治性子宫切除术(ORH)组的总生存期(OS,HR = 2.095,95%CI:1.233-3.562,P = 0.006)和无进展生存期(PFS,HR = 1.950,95%CI:1.194-3.184,P = 0.008)率显著高于腹腔镜根治性子宫切除术(LRH)组。然后根据FIGO 2018分期系统重新分期后,561例患者仍属于IA2-IIA2期,144例患者升级为IIIC1p-IIIC2p期。PS-IPTW分析后,ORH组的OS(HR = 1.977,95%CI:1.077-3.626,P = 0.028)和PFS(HR = 1.811,95%CI:1.046-3.134,P = 0.034)显著优于LRH组。此外,在无高中危因素的患者中,两组的OS(HR = 1.386,95%CI:0.287-6.69,P = 0.684)和PFS(HR = 1.524,95%CI:0.363-6.396,P = 0.565)率差异无统计学意义。
这项回顾性队列研究的结果符合2021年第1版美国国立综合癌症网络指南推荐的ORH适应症。然而,与ORH相比,LRH在无预后危险因素的患者中显示出非劣效性。